Concepts¶
(You can write manual introductory notes here. The AI will not overwrite them.)
Ideas, methods, pathways, and cross-cutting scientific topics.
Last updated: 2026-07-21
Contents¶
| Page | Summary | Tags | Updated |
|---|---|---|---|
| 1-Deoxysphingolipids (1-deoxySLs) | Atypical, neurotoxic sphingolipids synthesized when serine palmitoyltransferase (SPT) utilizes L-alanine instead of L-serine. | lipids, sphingolipids, neuropathy, toxicology, cell-death | 2026-07-19 |
| Activity-by-Contact (ABC) Model | A predictive model that links enhancers to target genes using chromatin activity and 3D contact frequency. | method, statistical-genetics | 2026-07-19 |
| Alternate RNA Decoding | Translation that deviates from the genetic code and produces amino acid-substituted proteoforms without a corresponding DNA or RNA sequence change. | proteomics, mass-spectrometry, functional-genomics | 2026-07-19 |
| AGER (Advanced Glycation End-Product Specific Receptor) | A receptor protein that mediates inflammatory signaling and has a strong genetic association with hypothyroidism risk. | gene, receptor, hypothyroidism, nf-kb, inflammation | 2026-07-19 |
| Biologically Informed Neural Networks | A neural network design philosophy that wires network connectivity to follow known biological hierarchies rather than dense layers, improving interpretability and small-sample performance. | deep-learning, computational-biology, bioinformatics, genomics, proteomics | 2026-07-20 |
| Branched-Chain Amino Acid (BCAA) Catabolism | The metabolic pathway responsible for the breakdown of branched-chain amino acids (valine, leucine, and isoleucine) into acyl-CoA derivatives. | pathway, metabolism, bcaa, type-2-diabetes | 2026-07-19 |
| Cardiac Adipose Tissue and Pericoronary Inflammation | The distinct roles of epicardial/pericardial adipose tissue (a largely visceral-adiposity trait) and pericoronary adipose tissue attenuation (a coronary-inflammation marker), and what their genetics captures. | cardiovascular-disease, medical-imaging, inflammation, adipocyte, gwas | 2026-07-21 |
| Cardiac Fatty Acid Oxidation and Cardiolipin Homeostasis | The relationship between myocardial fatty acid oxidation, cardiolipin abundance and mitochondrial function. | cardiology, lipid-metabolism, mitochondria, cell-death, metabolism | 2026-07-19 |
| Cardiometabolic Multimorbidity and Mortality | The mortality and life-expectancy burden associated with combinations of cardiometabolic diseases. | multi-morbidity, cardiovascular-disease, epidemiology, clinical | 2026-07-19 |
| Cell-Type Interaction QTLs | Computationally inferring cell-type-specific eQTLs and sQTLs from bulk GTEx tissue RNA-seq by testing genotype-by-cell-type-abundance interactions. | statistical-genetics, gwas, colocalization, gene-expression, genomics | 2026-07-20 |
| Chemosensory Mendelian Randomization | An epidemiological approach that utilizes genetic variants associated with taste and smell receptors as instrumental variables in Mendelian randomization studies of diet and health. | genetics, mendelian-randomization, chemosensory-perception, diet, epidemiology | 2026-07-19 |
| cis-Mendelian Randomization | A causal inference method in statistical genetics that uses genetic variants located in the cis-regulatory region of a gene as instrumental variables to estimate the effect of perturbing that gene's product on disease outcomes. | method, statistical-genetics, mendelian-randomization, causal-inference, drug-target | 2026-07-19 |
| Cryptic Splice Variants | Genetic variants located outside of canonical splice sites that create or disrupt splicing donor/acceptor sites. | gwas, statistical-genetics | 2026-07-19 |
| Disease Embedding Space | A word2vec-style continuous embedding of human diseases learned from 151 million patients' diagnosis histories, whose 20 dimensions can be genetically mapped via GWAS. | gwas, statistical-genetics, multi-morbidity, biostatistics, computational-biology | 2026-07-20 |
| DLKcat Generalization Failure and Train/Test Leakage | A methodological critique showing DLKcat's benchmark performance is driven by severe train/test data leakage, with accuracy collapsing for enzymes and mutants dissimilar to the training set. | machine-learning, enzyme-kinetics, benchmarking, methods-critique | 2026-07-20 |
| Enzyme Kinetic Parameter Prediction | The field of predicting enzyme kinetic parameters (kcat, Km, Ki, kcat/Km) from sequence via machine/deep learning, spanning bottom-up prediction, top-down calibration, and the unresolved DLKcat generalization dispute. | enzyme-kinetics, machine-learning, deep-learning, metabolic-modeling, protein-language-model | 2026-07-20 |
| Evolutionary-Scale Enzyme Kinetics Landscape Mapping | High-throughput microfluidic kinetic profiling of hundreds of adenylate kinase orthologs and mutants, mapping a rugged sequence-catalysis landscape and testing protein language models against it. | enzyme-kinetics, protein-language-model, evolutionary-biology, biochemistry | 2026-07-20 |
| Expert Oversight of AI in Bioinformatics | The argument that AI accelerates but cannot replace bioinformatics expertise, since AI outputs are only as valid as the domain judgement applied to design, data curation, interpretation, and institutional deployment. | bioinformatics, ai-in-healthcare, machine-learning, clinical-informatics | 2026-07-20 |
| Genetic Prediction of Multi-omic Traits | The computational imputation of transcriptomic, proteomic, and metabolomic features from host genotype data. | genomics, imputation, twas, pwas, mwas | 2026-07-19 |
| Genetic Architecture of Cardiometabolic Disease | Multi-ancestry mapping and functional interpretation of genetic risk for diabetes, coronary disease and stroke. | cardiovascular-disease, type-2-diabetes, gwas, multi-ancestry, fine-mapping | 2026-07-19 |
| Genetic Architecture of Heart Failure Subtypes | GWAS evidence that clinically-defined heart failure subtypes (HFrEF vs HFpEF, ischemic vs non-ischemic) have distinct genetic architectures, exemplifying the phenotype-first alternative to genetics-first PRS clustering. | cardiovascular-disease, heart-failure, gwas, disease-subtyping, multi-ancestry | 2026-07-21 |
| Genetics-Guided Therapeutic Target Discovery | Use of molecular QTLs, biobanks, Mendelian randomization and colocalization to prioritize drug targets and indications. | drug-target, drug-discovery, mendelian-randomization, colocalization, genomics | 2026-07-19 |
| Genetics of Subclinical Coronary Atherosclerosis Imaging | GWAS of CT-imaging endophenotypes of coronary atherosclerosis (coronary artery calcium; CCTA plaque burden), including evidence that calcification genetics is partly distinct from clinical CAD. | cardiovascular-disease, medical-imaging, gwas, multi-ancestry, pleiotropy | 2026-07-21 |
| Geometric Sketching | A transcriptomic downsampling method that selects representative subsets of cells by sampling uniformly across transcription space. | single-cell, transcriptomics, method | 2026-07-19 |
| GIPR (Gastric Inhibitory Polypeptide Receptor) | A G-protein coupled receptor that binds glucose-dependent insulinotropic polypeptide (GIP) and is targeted by dual-agonist medications like tirzepatide. | gene, receptor, obesity, type-2-diabetes, pharmacogenetics | 2026-07-19 |
| GLP-1 Receptor Agonists (GLP-1RAs) | A class of incretin-mimicking medications, including semaglutide and tirzepatide, used to treat obesity and type 2 diabetes. | pharmacology, obesity, type-2-diabetes, incretins | 2026-07-19 |
| GLP1R (Glucagon-Like Peptide 1 Receptor) | A G-protein coupled receptor that binds GLP-1 and is the primary target for GLP-1 receptor agonists used in obesity and diabetes treatment. | gene, receptor, obesity, type-2-diabetes, pharmacogenetics | 2026-07-19 |
| Intrahepatic Cholestasis of Pregnancy (ICP) | A gestational liver disorder characterized by pruritus and elevated serum bile acids, which shares genetic determinants and metabolic pathways with circulating lipids and glucose. | pathway, hepatology, pregnancy-complications, lipid-metabolism | 2026-07-19 |
| Human Lipidome Genetics | Genetic mapping of circulating molecular lipid species and their links to coronary artery disease. | lipidomics, genetics, lipid-metabolism, cardiovascular-disease, gwas | 2026-07-19 |
| Index-Event (Collider) Bias in Disease-Subtype Genetics | Why conditioning on being a case — in subtype, progression, or risk-factor-stratified genetic studies — induces spurious associations, and the methods that correct it. | statistical-genetics, causal-inference, collider-bias, mendelian-randomization | 2026-07-21 |
| Individual-First Polygenic Risk Score Clustering | Disease-subtyping approaches that cluster patients by their individual profile across several partitioned/component genetic scores, rather than clustering variants first. | polygenic-risk-score, disease-subtyping, clustering, gwas, statistical-genetics, type-2-diabetes, schizophrenia | 2026-07-21 |
| Kinetic Pathway Simulation for mGWAS Interpretation | Using kinetic models of a specific metabolic pathway, with enzyme reaction rates perturbed to mimic genetic variants, to distinguish causal from spurious mGWAS associations. | metabolomics, gwas, statistical-genetics, metabolic-flux-analysis, computational-biology | 2026-07-20 |
| Lipid Metabolic Flux Analysis (Lipid-MFA) | A modeling and analytical framework to quantify fatty acid synthesis, elongation, headgroup assembly, and recycling fluxes across the lipidome. | lipidomics, metabolic-flux-analysis, stable-isotope-tracing, mass-spectrometry | 2026-07-19 |
| Lipidomics Informatics Workflows | A staged approach to lipidomics data processing that preserves structural uncertainty while moving from spectra to biological interpretation. | lipidomics, bioinformatics, mass-spectrometry, pathway-analysis, computational-biology | 2026-07-21 |
| lncRNA Genetic Regulation and Disease Mapping | A systematic GTEx v8 characterization of 14,100 long non-coding RNA genes' expression, tissue specificity, genetic regulation, and colocalization with complex-trait GWAS loci. | genomics, gwas, statistical-genetics, gene-expression, colocalization | 2026-07-20 |
| Mechanism-First Polygenic Risk Score Clustering | Disease-subtyping approaches that first cluster GWAS variants/loci into biologically coherent groups by their multi-trait association pattern, then compute a partitioned polygenic score per cluster. | polygenic-risk-score, disease-subtyping, clustering, gwas, statistical-genetics, type-2-diabetes, obesity, hepatology, multi-ancestry | 2026-07-21 |
| Mendelian Randomization | A causal inference method in statistical genetics that uses genetic variants as instrumental variables to estimate the effect of an exposure on an outcome. | causal-inference, epidemiology, statistical-genetics, mendelian-randomization | 2026-07-19 |
| Metabolic Flux Modulation of Genetic Risk | The context-dependent amplification or buffering of disease-risk allele effects by organ-specific biochemical reaction activity. | metabolic-flux-analysis, systems-medicine, cardiovascular-disease, genetics, computational-biology | 2026-07-19 |
| Multi-Ancestry Proteome-Wide Association Studies | Training genetic prediction models of plasma protein abundance across diverse ancestries to enable proteome-wide association studies, and benchmarking multi-ancestry fine-mapping models for pQTL discovery. | proteomics, statistical-genetics, multi-ancestry, fine-mapping, twas | 2026-07-20 |
| Multimodal Disease Risk Prediction | A predictive paradigm that models multiple co-occurring diseases, input modalities, and prediction horizons simultaneously to capture the shared structure of human health. | risk-prediction, multimodal, clinical-informatics | 2026-07-19 |
| Multimodal Cardiovascular Risk Prediction | Cardiovascular risk estimation that combines clinical factors, metabolites and polygenic scores. | cardiovascular-disease, risk-prediction, metabolomics, polygenic-risk-score, multimodal | 2026-07-20 |
| Multivariate Latent-Factor Genetic Analysis | A summary-statistics workflow that derives GWASs of orthogonal latent factors from correlated high-dimensional traits and jointly fine-maps their association signals. | statistical-genetics, gwas, fine-mapping, multi-trait, bayesian | 2026-07-21 |
| Nightingale Health NMR Platform | A high-throughput metabolomics platform based on nuclear magnetic resonance spectroscopy that quantifies circulating lipids, lipoproteins, and low-molecular-weight metabolites. | metabolomics, nmr-spectroscopy, biomarker, high-throughput | 2026-07-19 |
| Oculomics | The study of using ophthalmic imaging biomarkers, such as retinal features, to predict and monitor systemic health, including cardiovascular and neurodegenerative diseases. | ophthalmology, biomarker, medical-imaging | 2026-07-19 |
| OMA1 (Mitochondrial Metalloendopeptidase) | A zinc-dependent metalloendopeptidase located in the inner mitochondrial membrane that regulates mitochondrial dynamics and stress signaling. | gene, receptor, mitochondria, neuropsychiatric, oma1 | 2026-07-19 |
| OR2T6 | Olfactory Receptor Family 2 Subfamily T Member 6 is a G-protein coupled receptor that detects volatile odorants and acts as a genetic proxy for onion liking. | gene, olfactory-receptor, sensory-perception, onion-liking, blood-pressure | 2026-07-19 |
| Polygenic and Gut Metagenomic Risk Integration | A prospective FINRISK 2002 cohort study finding PRS consistently improve prediction of four common diseases while gut microbiome scores add only modest, disease-specific incremental value. | polygenic-risk-score, genetics, risk-prediction, biostatistics, cohort | 2026-07-20 |
| Polygenic Risk Scores | An aggregate risk measure generated by summing the estimated effect sizes of multiple genetic variants associated with a particular disease or trait. | genetics, statistics, polygenic-risk-score, risk-prediction | 2026-07-21 |
| Polygenic-Score-Based Disease Subtyping | A field overview of three methodological families for using genetic data to identify clinically or mechanistically distinct disease subtypes: mechanism-first, individual-first, and subtype-prediction. | polygenic-risk-score, disease-subtyping, clustering, gwas, statistical-genetics | 2026-07-21 |
| Polygenic Subtyping of Cardiovascular Disease | State of the art and open directions for using partitioned/component polygenic scores to identify mechanistically distinct subtypes of coronary artery disease, myocardial infarction, and heart failure. | polygenic-risk-score, disease-subtyping, clustering, cardiovascular-disease, pleiotropy | 2026-07-21 |
| Plasma Proteogenomics | Large-scale integration of plasma protein measurements, genetic variation and disease phenotypes. | proteomics, genomics, biomarker, drug-target, systems-medicine | 2026-07-19 |
| Polygenicity-Induced Inflation in TWAS | The finding that pervasive polygenicity of a target trait inflates TWAS/xWAS false positive rates independent of LD contamination, and the variance-control correction developed to address it. | twas, statistical-genetics, gwas, polygenic-risk-score, biostatistics | 2026-07-20 |
| Program Search via Tree Search | An optimization methodology that combines language models with search algorithms to systematically locate high-performing code solutions. | method | 2026-07-19 |
| Proteogenomic Classification of IBD Subtypes | Using cross-platform pQTL-derived TWAS/PWAS signals and polygenic risk scores to distinguish Crohn's disease from ulcerative colitis in inflammatory bowel disease. | proteomics, genetics, polygenic-risk-score, gwas, biomarker, nf-kb | 2026-07-20 |
| Single-Cell Foundation Models | Overview of general-purpose deep learning models pretrained on large single-cell transcriptomic corpora and fine-tuned for downstream biological tasks. | single-cell, foundation-model, deep-learning, transcriptomics | 2026-07-19 |
| SMIM1 | A gene encoding small integral membrane protein 1, which determines the Vel blood group and is associated with red-cell traits. | gene, genetics, biomarker | 2026-07-19 |
| Small-Molecule Structure Elucidation | The process of identifying the chemical structure of small molecules from mass spectrometry data. | mass-spectrometry, metabolomics, structure-elucidation | 2026-07-19 |
| Statistical Colocalization | A statistical genetics approach to determine if two or more traits share a common causal genetic variant at a specific locus. | genetics, statistics, pleiotropy, fine-mapping, colocalization | 2026-07-19 |
| Subclinical Carotid Atherosclerosis Endotypes | Molecularly informed subclasses of subclinical carotid atherosclerosis with differing cardiovascular risk. | cardiovascular-disease, biomarker, causal-inference, proteomics, systems-medicine | 2026-07-19 |
| Subtype-Prediction Polygenic Risk Scores | Using already-derived partitioned polygenic scores for recognized genetic subtypes as fixed predictors of downstream clinical outcomes, rather than deriving new clusters. | polygenic-risk-score, disease-subtyping, gwas, statistical-genetics, type-2-diabetes | 2026-07-21 |
| Sum of Single Effects (SuSiE) Model | A Bayesian statistical framework for genetic fine-mapping that models association signals as a sum of single-effect regressions. | fine-mapping, bayesian, statistics, genetics | 2026-07-19 |
| TRIM5 | Tripartite motif-containing protein 5, an antiviral restriction factor that has been genetically linked to circulating lipoprotein levels and coronary artery disease risk. | gene, innate-immunity, lipoprotein-metabolism, cardiovascular-disease | 2026-07-19 |
| TWAS Signature-Matching | An in silico method integrating GWAS and eQTL data to generate disease signatures and match them against drug perturbation databases for candidate prioritisation. | bioinformatics, genomics, transcriptomics, drug-discovery, repositioning, twas | 2026-07-19 |
Categories¶
-
2026-07-21-lipidomics-infrastructure-ingest: lipidomics-informatics-workflows.md
-
2026-07-21-prs-subtyping-ingest: polygenic-score-based-disease-subtyping.md, mechanism-first-polygenic-risk-score-clustering.md, individual-first-polygenic-risk-score-clustering.md, subtype-prediction-polygenic-risk-scores.md, polygenic-subtyping-of-cardiovascular-disease.md, genetic-architecture-of-heart-failure-subtypes.md
-
2026-07-21-cvd-imaging-immune-ingest: genetics-of-subclinical-coronary-atherosclerosis-imaging.md, cardiac-adipose-tissue-and-pericoronary-inflammation.md, index-event-collider-bias-in-disease-subtype-genetics.md
-
2026-07-20-ingest: expert-oversight-of-ai-in-bioinformatics.md, proteogenomic-classification-of-ibd-subtypes.md
-
2026-07-20-enzyme-kinetics-ingest: dlkcat-generalization-failure-and-train-test-leakage.md, enzyme-kinetic-parameter-prediction.md, evolutionary-scale-enzyme-kinetics-landscape-mapping.md
-
2026-07-20-metaxcan-family-ingest: cell-type-interaction-qtls.md, disease-embedding-space.md, lncrna-genetic-regulation-and-disease-mapping.md, multi-ancestry-proteome-wide-association-studies.md, polygenicity-induced-inflation-in-twas.md
-
2026-07-20-metabolic-modeling-ingest: kinetic-pathway-simulation-for-mgwas-interpretation.md
-
2026-07-20-binn-ingest: biologically-informed-neural-networks.md
-
deep-ingest: metabolic-flux-modulation-of-genetic-risk.md, multivariate-latent-factor-genetic-analysis.md, smim1.md
-
2026-07-19-ingest: cardiac-fatty-acid-oxidation-and-cardiolipin-homeostasis.md, cardiometabolic-multimorbidity-and-mortality.md, genetic-architecture-of-cardiometabolic-disease.md, genetics-guided-therapeutic-target-discovery.md, human-lipidome-genetics.md, multimodal-cardiovascular-risk-prediction.md, plasma-proteogenomics.md, subclinical-carotid-atherosclerosis-endotypes.md
-
concept: 1-deoxysphingolipids-1-deoxysls.md, activity-by-contact-abc-model.md, alternate-rna-decoding.md, chemosensory-mendelian-randomization.md, cis-mendelian-randomization.md, cryptic-splice-variants.md, genetic-prediction-of-multi-omic-traits.md, geometric-sketching.md, glp-1-receptor-agonists-glp-1ras.md, intrahepatic-cholestasis-of-pregnancy-icp.md, lipid-metabolic-flux-analysis-lipid-mfa.md, mendelian-randomization.md, multimodal-disease-risk-prediction.md, nightingale-health-nmr-platform.md, oculomics.md, polygenic-risk-scores.md, program-search-via-tree-search.md, single-cell-foundation-models.md, small-molecule-structure-elucidation.md, statistical-colocalization.md, sum-of-single-effects-susie-model.md, twas-signature-matching.md
- gene: ager-advanced-glycation-end-product-specific-receptor.md, gipr-gastric-inhibitory-polypeptide-receptor.md, glp1r-glucagon-like-peptide-1-receptor.md, oma1-mitochondrial-metalloendopeptidase.md, or2t6.md, trim5.md
- pathway: branched-chain-amino-acid-bcaa-catabolism.md
Recent Changes¶
- 2026-07-21: Added Lipidomics Informatics Workflows from reviews of identification, quantification, statistics, ontology, pathway, and multi-omic integration
- 2026-07-21: Ingested an 8-paper CVD imaging/immune batch → added Genetics of Subclinical Coronary Atherosclerosis Imaging, Cardiac Adipose Tissue and Pericoronary Inflammation, and Index-Event (Collider) Bias in Disease-Subtype Genetics; rewrote the Polygenic Subtyping of Cardiovascular Disease proposal as a PGS-anchored, endophenotype-validated design
- 2026-07-21: Added Genetic Architecture of Heart Failure Subtypes (Joseph 2022 + HERMES 2024, ingested from user-supplied PDFs); verified/upgraded the 3 HF/MI citations on Polygenic Subtyping of Cardiovascular Disease and added a critical-appraisal section
- 2026-07-21: Added Polygenic Subtyping of Cardiovascular Disease from a query-driven integration + discovery pass (incorporates Hu et al. 2025 PD-PRS); cross-linked from Polygenic-Score-Based Disease Subtyping
- 2026-07-21: Added Polygenic-Score-Based Disease Subtyping, Mechanism-First, Individual-First, and Subtype-Prediction PRS clustering pages from a 13-paper ingest batch; augmented Polygenic Risk Scores and Multivariate Latent-Factor Genetic Analysis with cross-links
- 2026-07-20: Added Polygenic and Gut Metagenomic Risk Integration; augmented Polygenic Risk Scores and Plasma Proteogenomics with deep-learning-PGS and PGS-protein-mediation findings
- 2026-07-20: Added Biologically Informed Neural Networks
- 2026-07-20: Added Kinetic Pathway Simulation for mGWAS Interpretation; augmented Metabolic Flux Modulation of Genetic Risk with the foundational FWAS methodology paper
- 2026-07-20: Added Enzyme Kinetic Parameter Prediction, DLKcat Generalization Failure and Train/Test Leakage, and Evolutionary-Scale Enzyme Kinetics Landscape Mapping
- 2026-07-20: Added Cell-Type Interaction QTLs, Disease Embedding Space, lncRNA Genetic Regulation and Disease Mapping, Multi-Ancestry Proteome-Wide Association Studies, and Polygenicity-Induced Inflation in TWAS
- 2026-07-20: Added Expert Oversight of AI in Bioinformatics
- 2026-07-20: Added Proteogenomic Classification of IBD Subtypes
-
2026-07-20: Augmented Plasma Proteogenomics, Human Lipidome Genetics, Multimodal Cardiovascular Risk Prediction, Small-Molecule Structure Elucidation, Lipid Metabolic Flux Analysis (Lipid-MFA), and Polygenic Risk Scores with cross-links from the 2026-07-20 ingest batch
-
2026-07-19: Added Metabolic Flux Modulation of Genetic Risk
- 2026-07-19: Added Multivariate Latent-Factor Genetic Analysis